Adjuvant therapy for breast cancer

被引：20

作者：

Hortobagyi, G ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

来源：

ANNUAL REVIEW OF MEDICINE | 2000年 / 51卷

关键词：

chemotherapy; hormonal therapy;

D O I：

10.1146/annurev.med.51.1.377

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

substantial progress has been made in the diagnosis and management of primary breast cancer over the past three decades. As a result, mortality related to this disease has been decreasing gradually for several years, treatment has become more effective, and side effects and complications related to treatment have decreased. In this report, we review the state of adjuvant therapy for breast cancer.

引用

页码：377 / 392

页数：16

共 66 条

[21] Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: The University of Texas MD Anderson Cancer Center Experience [J].

Diamandidou, E ;

Buzdar, AU ;

Smith, TL ;

Frye, D ;

Witjaksono, M ;

Hortobagyi, GN .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) :2722-2730

[22]

*EARL BREAST CANC, 1992, LANCET, V339, P1

[23] ENDOMETRIAL CANCER IN TAMOXIFEN-TREATED BREAST-CANCER PATIENTS - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (NSABP) B-14 [J].

FISHER, B ;

COSTANTINO, JP ;

REDMOND, CK ;

FISHER, ER ;

WICKERHAM, DL ;

CRONIN, WM ;

BOWMAN, D ;

COUTURE, J ;

DIMITROV, NV ;

EVANS, J ;

FARRAR, W ;

KAVANAH, M ;

LICKLEY, HL ;

MARGOLESE, R ;

PATERSON, AHG ;

ROBIDOUX, A ;

SHIBATA, H ;

TERZ, J .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (07) :527-537

[24]

FISHER B, 1969, CANCER, V24, P1286, DOI 10.1002/1097-0142(196912)24:6<1286::AID-CNCR2820240639>3.0.CO

[25]

2-7

[26] Bisphosphonates: Mechanisms of action and clinical use in osteoporosis - An update [J].

Fleisch, H .

HORMONE AND METABOLIC RESEARCH, 1997, 29 (03) :145-150

[27] BONE-MARROW AUTO-TRANSPLANTATION FOR SOLID TUMORS - PROSPECTS [J].

FREI, E ;

ANTMAN, K ;

TEICHER, B ;

EDER, P ;

SCHNIPPER, L .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) :515-526

[28]

FREI EMIL, 1966, CANCER CHEMOTHERAP REP, V50, P1

[29] Cognitive dysfunction following adjuvant treatment of breast cancer: a new dose-limiting toxic effect? [J].

Ganz, PA .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (03) :182-183

[30] Life after breast cancer: Understanding women's health-related quality of life and sexual functioning [J].

Ganz, PA ;

Rowland, JH ;

Desmond, K ;

Meyerowitz, BE ;

Wyatt, GE .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :501-514

← 1 2 3 4 5 6 7 →